Fujimasa Tada Selected Research

Fujimasa Tada Research Topics

Disease

45	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 11/2012
7	Liver Neoplasms (Liver Cancer) 05/2024 - 12/2022
4	Neoplasms (Cancer) 12/2023 - 11/2012
4	Non-alcoholic Fatty Liver Disease 01/2023 - 03/2013
4	Infections 12/2020 - 03/2016
4	Insulin Resistance 06/2013 - 10/2011
3	Chronic Hepatitis C 02/2024 - 02/2019
3	Neoplasm Metastasis (Metastasis) 12/2023 - 11/2023
3	Hypertension (High Blood Pressure) 01/2023 - 01/2022
2	Hemorrhage 04/2024 - 11/2023
2	Thrombosis (Thrombus) 08/2023 - 01/2007
2	Alcoholic Fatty Liver 01/2023 - 08/2017
2	Fatigue 01/2023 - 01/2023
2	Inflammation (Inflammations) 01/2023 - 03/2013
1	Varicose Veins (Varicose Vein) 04/2024
1	Overweight 03/2024
1	Fibrosis (Cirrhosis) 02/2024
1	Esophageal and Gastric Varices (Esophageal Varices) 11/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 08/2023
1	Kidney Neoplasms (Kidney Cancer) 08/2023
1	Fatty Liver 02/2023
1	Proteinuria 01/2023
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023
1	Portal Hypertension 07/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 07/2021
1	Virus Diseases (Viral Diseases) 02/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Disease Progression 08/2017
1	Chronic Hepatitis B 03/2016
1	Chemical and Drug Induced Liver Injury 01/2015
1	Erythema 01/2015
1	Abdominal Pain (Pain, Abdominal) 01/2015
1	Asthma (Bronchial Asthma) 01/2015
1	Rupture 01/2015
1	Coinfection 01/2014
1	Obesity 03/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2013

Drug/Important Bio-Agent (IBA)

25	atezolizumabIBA 05/2024 - 01/2022
25	Bevacizumab (Avastin)FDA Link 05/2024 - 01/2022
15	lenvatinibIBA 04/2024 - 01/2023
8	AlbuminsIBA 05/2024 - 01/2023
7	BilirubinIBA 05/2024 - 01/2023
6	Antiviral Agents (Antivirals)IBA 04/2024 - 02/2019
4	B-Cell Activating FactorIBA 06/2013 - 10/2011
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 11/2023 - 08/2023
2	Fetal Proteins (Fetoprotein)IBA 05/2024 - 01/2023
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2022
2	Ribavirin (Virazole)FDA LinkGeneric 02/2019 - 01/2017
2	SofosbuvirIBA 02/2019 - 01/2017
2	Hemoglobins (Hemoglobin)IBA 01/2018 - 01/2015
2	AntigensIBA 01/2014 - 11/2012
2	AdipokinesIBA 03/2013 - 10/2011
1	Serum AlbuminIBA 10/2023
1	Tumor Biomarkers (Tumor Markers)IBA 08/2023
1	acarboxyprothrombin (PIVKA)IBA 08/2023
1	IronIBA 08/2023
1	CopperIBA 08/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2023
1	Proton Pump InhibitorsIBA 08/2023
1	RamucirumabIBA 02/2023
1	C-Reactive ProteinIBA 01/2023
1	Sorafenib (BAY 43-9006)FDA Link 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Therapeutic UsesIBA 11/2022
1	Monoclonal AntibodiesIBA 01/2022
1	CreatinineIBA 01/2022
1	Carbon Tetrachloride (Tetrachloromethane)IBA 07/2021
1	Indicators and Reagents (Reagents)IBA 07/2021
1	asunaprevirIBA 02/2019
1	daclatasvirIBA 02/2019
1	ledipasvirIBA 02/2019
1	ipragliflozinIBA 01/2018
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018
1	Alanine Transaminase (SGPT)IBA 01/2018
1	Sodium-Glucose Transport ProteinsIBA 01/2018
1	Palmitic AcidsIBA 08/2017
1	Palmitic Acid (Hexadecanoic Acid)IBA 08/2017
1	NucleosidesIBA 03/2016
1	entecavir FDA Link 03/2016
1	Ibuprofen (Motrin)FDA LinkGeneric 01/2015
1	IodineIBA 01/2015
1	Carbon DioxideIBA 01/2015
1	Nonprescription Drugs (Patent Medicines)IBA 01/2015
1	Contrast MediaIBA 01/2015
1	Tenofovir (Viread)FDA Link 01/2014
1	Glucose (Dextrose)FDA LinkGeneric 03/2013
1	Immunoglobulin G (IgG)IBA 03/2013
1	VaccinesIBA 11/2012
1	Neoplasm Antigens (Tumor Antigens)IBA 11/2012
1	Insulin (Novolin)FDA Link 10/2011
1	B-Cell Activation Factor ReceptorIBA 10/2011

Therapy/Procedure

20	Therapeutics 05/2024 - 01/2007
5	Radiofrequency Ablation 03/2024 - 11/2022
1	Catheters 10/2023
1	Aftercare (After-Treatment) 06/2021
1	Highly Active Antiretroviral Therapy (HAART) 01/2014
1	Immunotherapy 11/2012